Erythromelalgia following pergolide administration.
Two patients are described in whom treatment of Parkinson's disease with the ergot derivative pergolide was associated with the development of erythromelalgia. The possible mechanism of pergolide-induced erythromelalgia is briefly discussed.
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D004873:Ergolines / Q000009:adverse effects*; D004916:Erythromelalgia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D010479:Pergolide
D000978:Antiparkinson Agents; D004873:Ergolines; D010479:Pergolide